Does BOSUTINIB Cause Peripheral arterial occlusive disease? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Peripheral arterial occlusive disease have been filed in association with BOSUTINIB (BOSULIF). This represents 0.2% of all adverse event reports for BOSUTINIB.
16
Reports of Peripheral arterial occlusive disease with BOSUTINIB
0.2%
of all BOSUTINIB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From BOSUTINIB?
Of the 16 reports, 2 (12.5%) resulted in death, 4 (25.0%) required hospitalization.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSUTINIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does BOSUTINIB Cause?
Diarrhoea (1,820)
Nausea (886)
Fatigue (626)
Vomiting (469)
Death (465)
Rash (426)
Pleural effusion (398)
Neoplasm progression (376)
Dyspnoea (319)
Headache (283)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
Which BOSUTINIB Alternatives Have Lower Peripheral arterial occlusive disease Risk?
BOSUTINIB vs BOTOX
BOSUTINIB vs BOTOX COSMETIC
BOSUTINIB vs BOTULINUM TOXIN NOS
BOSUTINIB vs BOTULINUM TOXIN TYPE A
BOSUTINIB vs BREMELANOTIDE